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Immune responses demonstrate a high-level of intra-species variation, compensating 8 
for the specialization capacity of pathogens. The recent advent of high-depth immune 9 
phenotyping projects in large-scale cohorts has allowed a first look into the factors 10 
that shape the inter-individual diversity of the human immune system. Genetic 11 
approaches have identified genetic diversity as drivers of 20-40% of the variation 12 
between the immune systems of individuals. The remaining 60-80% is shaped by 13 
intrinsic factors, with age being the predominant factor, and environmental influences, 14 
with cohabitation and chronic viral infections identified as key mediators. Here we 15 
review and integrate the recent high-depth large-scale studies on human immune 16 
diversity, with its potential impact on health. 17 
  18 
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Dissecting Variation Through Population Immunology Studies 19 
The evolutionary arms-race between pathogens and hosts includes the constant 20 
refinement of host anti-pathogen mechanisms, and the reciprocal development of 21 
microbial strategies to circumvent these defenses [1]. While multi-cellular hosts bear 22 
the advantage of being able to specialize cells (our immune system) to the task of 23 
pathogen clearance, micro-organisms have the undoubted advantage in evolutionary 24 
speed. Because of this, the inter-individual diversity of the immune system in a 25 
species is an important mechanism for limiting the impact specific pathogens can 26 
have on the morbidity and mortality of a population. The maintenance of inter-27 
individual diversity within the immune system is therefore a critical aspect of its 28 
function, albeit one that is often neglected in immunological research, for example, 29 
through the use of genetically identical mice housed under specific pathogen free 30 
conditions [3]. 31 
The archetype of diversity generation in the human immune system is the production 32 
of extra-genomic variation in the antigen receptors of the adaptive immune system (T 33 
cell receptor and B cell receptor). The combination of permutational choice in gene 34 
fragment selection with an error-prone system creates an essentially personal T cell 35 
and B cell receptor repertoire for each individual, with response capacity further 36 
molded by the structural diversity encoded by the highly polymorphic MHC locus [4, 37 
5]. Clonal selection further shapes the repertoire in the periphery. However, even 38 
beyond the process of adaptive diversity, an enormous amount of variation exists in 39 
the number and functional status of each immunological component. Leukocytes, 40 
one of the key cellular mediators of the immune system, are epigenetically modified 41 
by the micro-environment and a myriad of other interactions to the point where each 42 
individual cell could be considered to exist in a unique status [6, 7]. These 43 
interactions shape the composition of an individual’s immune system over their 44 
lifespan, for example driving the differentiation of naïve T cells into subsets with 45 
specialized functions, resulting in the context-dependent generation of  Th1, Th2, 46 
Th17, follicular helper and regulatory  subsets [8].  47 
While a major focus of immunology research over the past decades has been in 48 
identifying and functionally dissecting these alternative activation states, there has 49 
been a growing appreciation that the plasticity of the immune system and the 50 
plethora of subsets and activation statuses results in dramatic individual-to-individual 51 
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variation in the immune system. In this review we concentrate on population 52 
immunology (see Glossary) studies, which we define as research which directly 53 
compares the status of the immune system (relative number of leukocyte subsets, 54 
activation status of leukocytes, production of non-cellular mediators) across a large 55 
number of individuals for the purpose of identifying the drivers of variation in the 56 
human immune system. 57 
Human Immune Variation 58 
The human immune system has a high degree of variation present between 59 
individuals. This variation manifests at the cellular and intra-cellular level, such as the 60 
differences in the relative frequency of different leukocyte populations and subsets, 61 
variation in the transcriptional and translational profiles of leukocyte subsets and 62 
variation in the functional capacity and polarization in response to immunological 63 
challenges such as vaccines [9]. This variability results in individuals with a different 64 
intrinsic susceptibility to different diseases. As an example, the concept of individuals 65 
being “Th1-biased” or “Th2-biased” is an articulation of this intrinsic variability, albeit 66 
a simplification of the multiple potential states the human immune system could 67 
adopt. More broadly, we consider the constellation of multiple cellular and molecular 68 
immune parameters within an individual to constitute the immune phenotype of that 69 
individual. 70 
The use of high detail longitudinal analysis of the human immune system has 71 
revealed this immune phenotype to be highly stable. In principle, the variation 72 
present in immune phenotypes within the human population could be generated 73 
through either of two mechanisms. First, the human immune system could undergo a 74 
continual flux within each individual (producing high levels of intra-individual 75 
variation), a process which would in turn produce a high degree of inter-individual 76 
variation (Figure 1a, Online Video 1). Alternatively, the immune profile of individuals 77 
could have relatively low levels of temporal variation in a given individual, but with 78 
highly divergent phenotypes between individuals (Figure 1b, Online Video 2). In this 79 
case, an individual immune phenotype would constitute a ‘stability island’, around 80 
which the immune parameters remain fixed over time. Multiple immune phenotyping 81 
studies, investigating the relative frequency of leukocyte subsets and activation 82 
states, have found that while inter-individual variation is high, the immune profile of 83 
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each individual is remarkable stable, even over the course of multiple months [10-13], 84 
favoring the second mechanism described above.  85 
The long-term stability of an individual’s immune system in the absence of 86 
immunological challenge does not require that stability is maintained during infection. 87 
One way to experimentally determine how an acute challenge impacts the immune 88 
system in humans is to use vaccination. This enables the global assessment of the 89 
immune system prior to, during, and following a known immunological stimulus [14]. 90 
There is a general pattern that emerges from these systems vaccinology studies that 91 
demonstrates the elastic response of the human immune system to acute challenge. 92 
The early phase of the immune response (0-3 days post vaccination) is characterised 93 
by the expansion of circulating antigen-presenting innate immune cells, which 94 
activate T cells. The resultant expansion of T cells and the production of antibody-95 
secreting plasma cells peak at 6-10 days post-vaccination, and are followed by a 96 
return to the pre-vaccination baseline [12, 13, 16-20]. The long-term functional 97 
memory T and B cells that persist [21, 22], are not present at a sufficient numbers to 98 
alter the cellular composition of the circulating immune system [12, 13, 16, 23-25]. In 99 
principle, an individual’s immune profile could elastically return to the original stable 100 
state following this immunological challenge (Figure 1c, Online Video 3), or the 101 
transient changes caused during infection could cause it to settle into a new stable 102 
immunological state (Figure 1d, Online Video 4). The data for both gastrointestinal 103 
infection (traveller’s diarrhoea) and influenza vaccination in people suggest that the 104 
‘elastic rebound’ model is appropriate [13]. In other words, individuals will generally 105 
return to an immune phenotype similar to their original state after an acute immune 106 
stimulus, although chronic infections may be an exception (see dedicated section 107 
below). The presence of these two characteristics, longitudinal stability and elastic 108 
rebound after challenge, allows the further dissection of which factors shape 109 
diversity. 110 
Intrinsic Factors Influencing the Human Immune System 111 
Age 112 
With advancing age the function of the immune system declines, rendering older 113 
persons more susceptible to infection and less able to generate protective immunity 114 
after vaccination [26]. Population immunology studies that have included age as a 115 
variable have found that aging impacts on ~20% of immunological traits, and overall 116 
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contributes ~5% of total immune variation [10, 11, 13, 27]. Analysis of the specific 117 
traits impacted demonstrates that the ageing human immune system is largely 118 
characterized by a decrease in the frequency of precursor cells, and an increase in 119 
the number of T cells with an activated or memory phenotype [10, 11, 13, 27, 28]. 120 
The changing immune landscape over time is likely driven by a number of biological 121 
mechanisms. As the immune system is constantly interacting with both pathogens 122 
and commensals, it is thought that these interactions play a key role in shaping the 123 
human immune system, such as by increasing the number of memory cells with age 124 
[29]. However, work with germ-free mice demonstrates that T cells that have not 125 
‘seen’ their cognate antigen can acquire a memory phenotype via homeostatic 126 
expansion [30, 31]. Memory phenotype cells are found in human cord blood 127 
suggestive of homeostatic expansion [32], but the assumed sterility of the in utero 128 
environment is questionable [33]. Ageing is characterized by an increase in 129 
proinflammatory cytokines, which alter the environment of the immune system. This 130 
in turn may alter the phenotype and function of immune cells in an antigen-131 
independent way [34].  Because humans maintain their naïve T cell pool for decades 132 
by peripheral T cell division alone [35], and as the long-term impact of a single 133 
immune challenge is minute in the immune landscapes of healthy people [12, 13], it 134 
is plausible that the age-dependent skewing of the immune system from a naïve to 135 
memory phenotype may occur, in part, without recognition of cognate antigen or as a 136 
result of cross-reactivity [36, 37]. 137 
Despite the clear role for non-genetic factors shaping the ageing immune system, 138 
cellular phenotypes associated with ageing, for example the decline in thymic output 139 
and thus numbers of recent thymic emigrants, have high heritability [10, 11, 13, 38]. 140 
This suggests that the interplay of genetic and non-genetic factors is important for the 141 
development of ageing phenotypes. While the role for selection of genes that impact 142 
ageing phenotypes is an area of intense debate [39], human longevity studies show a 143 
clear role of genetics in impacting how well we age [40]. Specific studies on how 144 
genetics shape the human immune system have yet to be realized. Nevertheless, 145 
single nucleotide polymorphisms associated with longevity are also linked with 146 
functional changes in the immune system [40-42], suggesting a link between 147 
immunity, inflammation and health in older age. 148 
Sex 149 
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It is clear that there is sexual dimorphism in immune-related pathology. In general, 150 
autoimmune diseases are more common in women than men [43], while men are 151 
more susceptible to infections caused by viruses, bacteria, parasites and fungi [44]. 152 
There is also evidence that women produce higher antibody titers in response to 153 
vaccination than men, suggesting sex can impact immune function [44]. Despite clear 154 
differences in functional outcome, the differences in the cellular composition of the 155 
immune system between men and women are few; women tend to have a higher 156 
CD4+ T cell count, and lower natural killer (NK) cell counts than men, but otherwise 157 
no consistent differences are observed [13, 27, 45], suggesting sex has a larger 158 
influence on disease outcome than immune composition. This is supported by large 159 
scale phenotyping of clinical and immunological parameters in parallel, that indicates 160 
that sex has the largest effect on clinical phenotypes [27]. Interestingly, the functional 161 
and cellular differences between the sexes are more pronounced in men with high 162 
testosterone [46], and disappear after menopause [44, 45], suggesting that the sex 163 
hormones are responsible for these changes, although precisely how this is mediated 164 
has yet to be elucidated.  165 
Genetic Control Over Human Immune Variation 166 
A likely driver for individual-to-individual variation in the settings of the immune 167 
system is genetic variation. Indeed, major studies into the genetic basis of variation in 168 
the cellular and molecular composition of the human immune system have found that 169 
genetic variation (e.g. common and rare variants, variations in copy number) 170 
accounts for 20-40% [10, 11, 47, 48] of total immunological variation (Figure 2). 171 
These studies have used either a twin or familial structure to estimate heritability. The 172 
twin studies use the classical ACE model (see Glossary), while Orrù et al. use a 173 
kinship matrix based on genotype to define relatedness [11]. Heritability estimates 174 
should therefore be considered with a broad definition of genetic variation, including 175 
(but not limited to) common, copy number and rare variants; heritable epigenetic 176 
modification and genotype-genotype interactions (for example, interactions between 177 
Killer immunoglobulin-like receptor gene variants and HLA variants determine the 178 
severity of CMV infection [49]. 179 
The range of heritability estimates, from 20 to 40% of total immunological variance, is 180 
likely to reflect both biological differences in the populations being measured and 181 
methodological differences in sampling and the choice of which immunological 182 
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parameters to include in the study of overall immune diversity. In this regard, it is 183 
notable that the highest estimates came from analysis of the Sardinian population 184 
(which is a genetic isolate). The lowest level of heritability was reported by Ye et al. 185 
[47]. There were several features unique to this study: (i) transcriptome-level 186 
analysis; (ii) tightly controlled sampling protocol (with only sampling between the 187 
hours of 07:30-08:30, from fasted participants); (iii) cells were examined both ex vivo 188 
and after stimulation and (iv) heritability was estimated from principal components 189 
based on ancestry. It is tempting, when comparing the lower heritability in Ye et al. to 190 
the other studies, to speculate that the transcriptome might well have a larger total 191 
variance than the cellular composition of the immune system. For instance, it seems 192 
plausible that the absolute expression of CD4 mRNA may vary more markedly than 193 
the frequency of CD4+ T cells. In support of this proposition, an older study using only 194 
basic immune populations found a much higher heritability estimate of ~70% [50]. 195 
This would indicate a hierarchy of genetic influence, with the strongest effects being 196 
felt at the leukocyte population level, moderate effects at the level of subsets and 197 
activation potential, and the weakest effects at the level of transcription. By inference, 198 
environmental effects are likely to be strongest at the molecular level and would have 199 
the weakest potential to influence major leukocyte populations. An exception may be 200 
cis-acting regulatory polymorphisms, with some of the highest heritability found for 201 
single protein expression markers and their corresponding gene (for example CD39 202 
expression with ENTPD1, the CD39 gene, variants [38]). While it is debatable as to 203 
which level of immune variation is the most relevant, given that the basic unit of 204 
immunity is the cell it seems reasonable to us to focus on the variation present at the 205 
level of cellular subset and function, rather than lower-order (transcriptome, single 206 
gene expression) or higher-order (basic leukocytes) variation. 207 
Beyond gross heritability analysis, several studies have explored the relationship 208 
between specific genetic variants and individual immune parameters. To date, only 209 
associations with common single nucleotide polymorphisms (SNP) have been 210 
explored [11, 38, 47]. The relatively low number of individuals assessed in this 211 
manner (compared to disease-based genome-wide association studies), and the 212 
multiple classes of genetic variants missing from these studies (Box 3), preclude final 213 
conclusions being made – there is more to be found from genetic analyses. However, 214 
as may be expected, many of the SNPs identified that are associated with changes in 215 
immune cell types are in or near genes with known functions in the immune system, 216 
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and in particular within genes that have been previously associated with 217 
autoimmunity, inflammatory diseases and susceptibility to infection [11, 38]. These 218 
findings strongly support the supposition that diversity in the immune system 219 
contributes to the relative risk of the individual to develop immunological disease.  220 
Environmental Influences on Human Immune Variation 221 
The estimate of the contribution heritable (20-40%) and intrinsic factors (~5%) make 222 
to the observed immunological variation suggests a major role for environmental 223 
factors. Unlike genetic and intrinsic factors, which are readily identifiable and 224 
measureable, dissecting out the individual environmental factors that may play a role 225 
is confounded by the limitless list of putative environmental factors that could be 226 
considered, the difficulty in collecting data for any of these factors, and the unknown 227 
timeframe over which environmental factors may be acting. Nevertheless, there are 228 
indications of the potency and nature of environmental contributors to immunological 229 
variation. We recently assessed the immunological variation that is present between 230 
opposite sex couples living with a child and found that the degree of variation was 231 
50% lower than is observed in the general public [13], indicating that a convergence 232 
in immune status occurs during cohabitation (Figure 3 and online video 5). Even 233 
with the proviso that couples are not randomly assorting, this data indicates that 234 
environmental factors are potent, that they can modify the adult immune system, and 235 
that they can be observed at the level of the household. The cohabitation effect is 236 
likely to be driven through the accumulated impact of multiple smaller factors, as the 237 
reduction of diversity evident within each couple was unique [13] (while convergence 238 
driven by a single environmental factor would be expected to show a consistent effect 239 
across multiple couples). 240 
There are multiple promising candidates for the household environmental factors 241 
capable of shaping the variation present in the human immune system. One of the 242 
strongest is likely to be chronic viral infections, with discordance in cytomegalovirus 243 
infection a major driver of immune diversity between monozygotic twins [10] (see 244 
detailed section below). Other factors that are shared within household members and 245 
are known to alter the immune state, and which could therefore drive household-level 246 
immunological convergence, include smoking status [51], well-being [52, 53], pet 247 
ownership [54], physical activity [55], obesity [13], diet [56] and environmental 248 
pollutants [57, 58]. Each of these factors is also likely to influence the composition of 249 
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that individual’s microbiota. The indirect microbiota convergence between individuals 250 
that share an environment (and thus the same microbiota modifiers) is also 251 
accompanied by direct transmission of microbiota between individuals in close 252 
proximity, enhancing microbiota convergence [59-62]. With the growing evidence that 253 
the microbiota composition, especially within the gut, influences the immune system 254 
[63-67], it is plausible that microbiota changes act as an integrator of multiple 255 
environmental factors, in turn shaping diversity within the human immune system. 256 
Seasonal change is another environmental factor that can influence immune variation 257 
[68], however it is unlikely to be captured in most study designs, as it would not 258 
induce variation between individuals living in the same region at a given time-point.  259 
Bacteria and viruses are both able to establish chronic infections. For example 260 
Mycobacterium tuberculosis and cytomegalovirus (CMV) are able to persist long-term 261 
in humans. Such infections can be established when the pathogen is able to evade 262 
sterilizing immunity, followed by formation of an equilibrium between the pathogen 263 
and host in which the inflammatory response is reduced to a level that can control the 264 
pathogen without causing excess damage to the host [69, 70]. The balance between 265 
host and chronic infectious agents is a complex one; ultimately the pathogen requires 266 
a live host for its continued survival so must exist in a balance of not triggering overt 267 
immunity and clearance, and not overcoming the host with disease. This constant 268 
interaction with the host immune system has an indelible impact on the immune 269 
landscape. 270 
There are a number of chronic viral infections that rarely cause disease in healthy 271 
hosts with symptoms only becoming apparent in immunocompromised individuals 272 
[69]. Despite the lack of clinical disease, this long-term dynamic interaction between 273 
host and virus has significant impact on altering the cellular composition of the 274 
immune system. The best characterised of these persistent infections are CMV and 275 
Epstein-Barr virus (EBV). CMV influences the immune system directly, by increasing 276 
the frequency of CMV-specific CD4+ and CD8+ T cells to around 5% of the total T cell 277 
pool in people under 55 years old [71], the frequency of CMV specific cells increases 278 
further with age suggesting a dynamic host-pathogen interaction that continues to 279 
shape the immune system [29]. This effect is likely due to the combined impact of 280 
thymic involution with the continued stimulation of CMV-specific T cells clones 281 
throughout life [72]. The effects of CMV are not limited to antigen-specific T cells; 282 
global analysis of the immune systems either unrelated individuals or monozygotic 283 
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twins that are discordant for CMV demonstrate that presence of this virus alters the 284 
level of certain serum cytokines, such as IL-6, and frequency of many cell types 285 
including γδ T cells, granulocytes and memory CD8+ T cells [10, 27]. It is clear that 286 
CMV has significant effects on the composition of the immune system, and intriguing 287 
that it seems to be the most extreme example of a persistent infection impacting the 288 
host in this way. A caveat for the role of CMV in these studies, is that their 289 
concordance for other chronic infections was not assessed [10]. However, individuals 290 
infected with herpes simplex virus do not exhibit the type of changes in their 291 
circulating T cell compartment that are driven by CMV [73]. Persistent EBV infections 292 
that have not caused acute disease (infectious mononucleosis) also result in the 293 
accumulation of virus-specific CD4+ and CD8+ T cells, but not as high a frequency as 294 
CMV specific T cells [74, 75].  295 
Concluding Remarks 296 
The advent of large-scale high-depth immune profiling (“population immunology”) has 297 
allowed a first insight into the scope and nature of immune diversity within the human 298 
population. In the case of systems vaccinology, this variation has a clear potential 299 
impact on health, with altered efficacy of vaccination against infectious diseases [12, 300 
18]. However, variation in the human immune system is likely to not only influence 301 
responses to infections, but also to impact on susceptibility to autoimmunity, allergy, 302 
cancer and the inflammatory diseases of ageing, such as diabetes, cardiovascular 303 
disease and neurodegeneration. To a certain degree this variation, and the resulting 304 
disease susceptibility, is ‘locked in’, owing to the influence of genetic and intrinsic 305 
factors. However, a surprisingly high influence of environmental control has also 306 
been observed, such as is revealed by the effect of cohabitation [13]. New studies 307 
need to be performed to identify the distinct interactions between environment and 308 
immune variation, however for parameters such as microbiome [64], diet [56], air 309 
pollution [57] and even anxiety [53], it is likely that much of the influence they have 310 
over disease susceptibility will lie in their capacity to modulate the immune system. 311 
Dissections of the particular environment-immune interactions that constitute disease 312 
risk have the potential to allow targeted modification of the immune system by 313 
lifestyle and environmental modulation (see Outstanding Questions). Regulation of 314 
environmental influences over the immune system through approaches such as 315 
dietary modification, restricting exposure to certain pollutants and monitoring 316 
microbiota changes would combine aspects of personalized medicine with 317 
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preventative medicine, and could have a profound impact on the way immunological 318 
health is managed. 319 
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Figure legends 512 
 513 
 514 
 515 
 516 
Box 1. Limitations in SNP Genotyping Platforms 517 
The SNP genotyping platforms typically used for genome-wide association studies 518 
place an emphasis on common single nucleotide (>5% allelic frequency), which 519 
accounts for ±90% of genetic variation in the human population [76]. This excludes 520 
certain classes of genetic variation, notably copy number variation and rare variants, 521 
which, while less common, may exert a disproportionate degree of influence over the 522 
immune system. SNP genotyping platforms can also struggle with immunological loci, 523 
owing to the enrichment for gene duplication events [77, 78]. For example, the 524 
rs1050501 SNP in FCG2RB, confers susceptibility to systemic lupus erythematosus 525 
and protection from malaria [79]. The pseudogene FCGR2C has an identical 526 
nucleotide sequence in this exon, but is homozygous for the ancestral allele. 527 
Genome-wide SNP platforms will discard rs1050501 at the quality control stages, as 528 
it will not follow Hardy-Weinberg equilibrium (that allele frequencies will remain 529 
constant across generations in the absence of selection pressure) due to 530 
contaminating signal from FCGR2C. These effects place a technical burden on 531 
estimating the contribution of such loci, which may cause an under-estimation of the 532 
genetic contribution of immunological loci.  533 
Figure 1. Opposing Models for the Properties of Human Immune Variation. 534 
Variation in the immune system can be represented as different points that can be 535 
occupied on an ‘immunological landscape’. A. The stochastic model is based on a 536 
fluctuating immune system, where apparent diversity is observed due to taking single 537 
snap-shots of an immune system in flux. B. The stability model is based on 538 
individual-to-individual variation reflecting a consistent longitudinal difference, with 539 
only minor changes occurring within healthy individuals monitored over time. The 540 
stability model raises additional possibilities of elastic or inelastic stability. C. The 541 
elastic stability model is based on individuals maintaining distinct immune variation, 542 
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consistently across time. While immunological disturbances (such as infection) can 543 
transiently alter the state, following the end of the disturbance, individuals ‘rebound’ 544 
to the original state. D. The inelastic stability model also has maintenance of distinct 545 
immune variation over time, however immunological challenges can disrupt the 546 
default state, resulting in a different stable state being achieved. The white flashes in 547 
C and D represent a immunological challenge, such as vaccination, or infection. 548 
Figure 2. Heritability of Immune Traits Across Different Populations and Study 549 
Designs. Published heritability estimates for individual immune traits. For each study, 550 
the study design, numbers of individuals and measurement strategy (blue, twin study; 551 
orange, family study) is displayed. For Ye et al., heritability estimates for each 552 
individual trait were unavailable; the ‘global’ reported estimate is shown; this study 553 
used a population study design. Boxes depict interquartile range (IQR) and median. 554 
The whiskers extend up to the furthest datapoint or 1.5 x IQR, in which case outliers 555 
are plotted with dots. Abbreviations used: MZ monozygotic; DZ dizygotic. 556 
 558 
Figure 3. Interaction of Genetics, Age and Environment on Immune Variation. 559 
Immune variation can be modeled as an ‘immunological landscape’, with individuals 560 
occupying different points on the landscape. A synthesis of current data would place 561 
the role of genetics as influencing the initial starting point on the immune landscape. 562 
This initial variation is molded by age, with predictable changes occurring over time, 563 
driving the same changes in different individuals. Local environment strongly modifies 564 
other variables, leading to factors such as cohabitation (pink) resulting in 565 
convergence between different individuals to a closer point on the immunological 566 
landscape.  567 
Online Video 1. The Stochastic Model of Human Immune Variation. Variation in 568 
the immune system can be represented as different points that can be occupied on 569 
an “immunological landscape”. The stochastic model is based on a fluctuating 570 
immune system, where apparent diversity is observed due to taking single ‘snap-571 
shots’ of an immune system in flux. Under this model, the relative diversity between 572 
individuals will change dramatically over time, as each individual constantly moves 573 
through the immunological landscape. 574 
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Online Video 2. The Stability Model of Human Immune Variation. Variation in the 575 
immune system can be represented as different points that can be occupied on an 576 
“immunological landscape”. The stability model is based on individual-to-individual 577 
variation reflecting a consistent longitudinal difference, with only minor changes 578 
occurring within healthy individuals monitored over time. In this model, the immune 579 
system of individuals can vary with time, but this variation is largely contained to a 580 
limited region on the immunological landscape (visualized through a depression in 581 
the landscape). The current data obtained from population immunology studies 582 
supports this model over the one presented in Video 1. 583 
Online Video 3. The Elastic Stability Model of Human Immune Variation. 584 
Variation in the immune system can be represented as different points that can be 585 
occupied on an “immunological landscape”. The stability model is based on 586 
individual-to-individual variation reflecting a consistent longitudinal difference, with 587 
only minor changes occurring within healthy individuals monitored over time. In this 588 
model, the immune system of individuals can vary with time, but this variation is 589 
largely contained to a limited region on the immunological landscape during the 590 
homeostatic context (visualized through a depression in the landscape). Despite this 591 
stability during homeostasis, the immune system can radically change during 592 
infection (visualized through the individuals turning black). Under the elastic stability 593 
model, these immunological disturbances are only transient, and following the end of 594 
the disturbance, individuals “rebound” to the original homeostatic state. Current data 595 
seems to support this model in most cases. 596 
Online Video 4. The Inelastic Stability Model of Human Immune Variation. 597 
Variation in the immune system can be represented as different points that can be 598 
occupied on an “immunological landscape”. The stability model is based on 599 
individual-to-individual variation reflecting a consistent longitudinal difference, with 600 
only minor changes occurring within healthy individuals monitored over time. In this 601 
model, the immune system of individuals can vary with time, but this variation is 602 
largely contained to a limited region on the immunological landscape during the 603 
homeostatic context (visualized through a depression in the landscape). Despite this 604 
stability during homeostasis, the immune system can radically change during 605 
infection (visualized through the individuals turning black). Under the inelastic stability 606 
model, these immunological disturbances create a lasting imprint on the individual’s 607 
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immune variation, with a new homeostatic state being established at the resolution of 608 
infection. Infections that can establish chronicity are a good example of this model. 609 
Online Video 5. Interaction of Genetics, Age and Environment on Immune 610 
Variation. Immune variation can be modeled as an “immunological landscape”, with 611 
individuals occupying different points on the landscape. A synthesis of current data 612 
would place the role of genetics as influencing the initial homeostatic stability region 613 
on the immune landscape. Individuals show minor variation within their unique 614 
stability region over the short-term, however over the long-term the region of stability 615 
is molded by age, with predictable changes occurring over time, driving the same 616 
changes in different individuals (visualized by the downwards movement of the 617 
depression). In addition to the effect of age, local environment strongly modifies other 618 
variables, with factors such as cohabitation (with the pink flash indicating the initiation 619 
of cohabitation between the visualized individuals) resulting in convergence between 620 
the individuals to a closer point on the immunological landscape.  621 
 622 
Glossary 623 
Population immunology : The study of human immunology where the primary focus 624 
is to under the diversity of immune states and responses across a large population. 625 
Population immunology studies need to combine a high depth (e.g., detailed analysis 626 
of leukocyte population subsets or function) with large population size (typically 627 
between 100 and 1000 individuals) in order to identify the degree of immune variation 628 
and potential drivers. 629 
ACE model: In the ACE model, total phenotypic variance is considered to be the 630 
sum of the variances attributed to genetic (A), common environmental (C) and unique 631 
environmental (E) factors. Twins share C and E, with monozygotic twins fully sharing 632 
A and dizygotic twins sharing 50%. Thus the assessment of multiple sets of 633 
monozygotic and dizygotic twins allows an estimation of the proportion of total 634 
phenotypic variance that is driven by genetic variation.  635 
 636 
